Experts express concern over the accuracy and data privacy of AI-powered health gadgets showcased at CES, especially as the U.S. government eases regulations on low-risk wellness products. The FDA announced relaxed rules for devices like heart monitors, aligning with the administration's broader strategy to foster AI innovation by removing regulatory barriers.